Skip to main content
OpenTrials

Clinical trial condition

Salivary Gland Neoplasms

Explore clinical trials studying Salivary Gland Neoplasms. Study availability and eligibility vary by location and protocol.

190 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Salivary Gland Neoplasms trial results

Active, Not Recruiting

APG-115 in Salivary Gland Cancer Trial

NCT03781986

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +12 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

NCT03942653

Conditions
Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
Locations
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Univeristy of Maryland Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma

NCT04325828

Conditions
Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +5 more
Locations
  • National Cancer Center Hospital Chūōku, Japan
  • National Hospital Organization Kyushu Medical Center Fukuoka, Japan
  • Kansai Medical University Hospital Hirakata, Japan
  • National Hospital Organization Shikoku Cancer Center Matsuyama, Japan
View Trial Details
Active, Not Recruiting

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

NCT02650401

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Brain Diseases, +59 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Egleston Children's Hospital at Emory University Atlanta Atlanta, Georgia, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

NCT05669664

Conditions
Head and Neck Neoplasms, Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, +9 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT00588770

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 781 locations
View Trial Details
Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details

Related conditions